Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three cases of late-onset oligomeganephronia.
Kawanishi K, Takei T, Kojima C, Moriyama T, Sugiura H, Itabashi M, Tsukada M, Uchida K, Honda K, Nitta K. Kawanishi K, et al. Among authors: kojima c. NDT Plus. 2011 Feb;4(1):14-6. doi: 10.1093/ndtplus/sfq175. Epub 2010 Oct 12. NDT Plus. 2011. PMID: 25984091 Free PMC article.
[Case of MMF monotherapy for membranous nephropathy].
Kobayashi M, Kojima C, Sugiura H, Aoki A, Itabashi M, Tsukada M, Takei T, Uchida K, Nitta K. Kobayashi M, et al. Among authors: kojima c. Nihon Jinzo Gakkai Shi. 2010;52(5):572-7. Nihon Jinzo Gakkai Shi. 2010. PMID: 20715589 Japanese.
Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function.
Moriyama T, Amamiya N, Ochi A, Tsuruta Y, Shimizu A, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K. Moriyama T, et al. Among authors: kojima c. Clin Exp Nephrol. 2011 Oct;15(5):700-707. doi: 10.1007/s10157-011-0455-8. Epub 2011 May 31. Clin Exp Nephrol. 2011. PMID: 21625892
The characteristics of relapse in adult-onset minimal-change nephrotic syndrome.
Takei T, Koike M, Suzuki K, Shirota S, Itabashi M, Ohtsubo S, Sugiura H, Suzuki K, Kojima C, Takahashi M, Ino J, Ogawa T, Uchida K, Tsuchiya K, Yumura W, Nitta K. Takei T, et al. Among authors: kojima c. Clin Exp Nephrol. 2007 Sep;11(3):214-217. doi: 10.1007/s10157-007-0484-5. Epub 2007 Sep 28. Clin Exp Nephrol. 2007. PMID: 17891348
Effect of single-dose rituximab on primary glomerular diseases.
Sugiura H, Takei T, Itabashi M, Tsukada M, Moriyama T, Kojima C, Shiohira T, Shimizu A, Tsuruta Y, Amemiya N, Ogawa T, Uchida K, Tsuchiya K, Nitta K. Sugiura H, et al. Among authors: kojima c. Nephron Clin Pract. 2011;117(2):c98-105. doi: 10.1159/000319656. Epub 2010 Aug 6. Nephron Clin Pract. 2011. PMID: 20693810
Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.
Takei T, Itabashi M, Tsukada M, Sugiura H, Moriyama T, Kojima C, Shiohira S, Shimizu A, Karasawa K, Amemiya N, Kawanishi K, Ogawa T, Uchida K, Tsuchiya K, Nitta K. Takei T, et al. Among authors: kojima c. Intern Med. 2010;49(19):2065-70. doi: 10.2169/internalmedicine.49.3707. Epub 2010 Oct 1. Intern Med. 2010. PMID: 20930431 Free article. Clinical Trial.
344 results